Showing results (111-120 of 333) with videos related to
Sort By:
Pageof 34
Blood Cancer Discovery|September 21, 2020
Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progressionMarta Chesi, Caleb K Stein, Victoria M Garbitt, et al.Blood Cancer Discovery|July 12, 2021
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapySima Jeha, John Choi, Kathryn G Roberts, et al.Blood Cancer Discovery|July 14, 2021
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal HematopoiesisLaura W Dillon, Jack Ghannam, Chidera Nosiri, et al.Blood Cancer Discovery|July 14, 2021
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple MyelomaHiroto Ohguchi, Paul M C Park, Tingjian Wang, et al.Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.Blood Cancer Discovery|September 27, 2021
Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid LeukemiaKyle A Romine, Tamilla Nechiporuk, Daniel Bottomly, et al.Blood Cancer Discovery|December 3, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T CellsSamy Jambon, Jianping Sun, Shawn Barman, et al.Blood Cancer Discovery|March 20, 2025
Unleashing the Full Potential of Metabolic Interventions in T-ALLVictoria da Silva-Diz, Daniel HerranzBlood Cancer Discovery|October 18, 2024
Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant MicroenvironmentDeepak Singhal, Monika M Kutyna, Christopher N Hahn, et al.Blood Cancer Discovery|May 1, 2024
"Myeloid" Mutations in ALL Are Not Uncommon: Implications for Etiology and TherapiesIlaria IacobucciPageof 34